European Neuropsychopharmacology impact factor, indexing, ranking (2022)


European

Aim and Scope

European Neuropsychopharmacology is a research journal that publishes research related to Psychiatry and Mental Health. This journal is published by Elsevier. The P-ISSN of this journal is 0924977X.

Also, check the other important details below like Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate of European Neuropsychopharmacology.

European Neuropsychopharmacology Ranking

Impact Factor: 5.415
Total Citations: 9792
SJR (SCImago Journal Rank): 1.603
Quartile: Q1

The Impact Factor of European Neuropsychopharmacology is 5.415.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times its articles are cited.

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI) in Philadelphia. Impact factors began to be calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson-Reuters spun off and sold ISI to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.

Important Metrics

Journal Title: European Neuropsychopharmacology
Publisher: Elsevier
P-ISSN: 0924977X
Open Access: NO
Subject: Psychiatry and Mental Health
Citescore: 6.3
SNIP: 1.26
SJR: 1.603
Quartile: 1

European Neuropsychopharmacology Indexing

The European Neuropsychopharmacology is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).


European Neuropsychopharmacology Impact Factor 2022

The latest impact factor of European Neuropsychopharmacology is 5.415.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times it's articles are cited.


European Neuropsychopharmacology Quartile

The latest Quartile of European Neuropsychopharmacology is Q1.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.



Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in European Neuropsychopharmacology?

This journal covers the fields/ categories related to Psychiatry and Mental Health. If your research field is related to Psychiatry and Mental Health, then visit the official website of European Neuropsychopharmacology and send your manuscript.

Tips for publishing in European Neuropsychopharmacology:

  • Selection of research problem.
  • Presenting a solution.
  • Designing the paper.
  • Make your manuscript publication worthy.
  • Write an effective results section.
  • Mind your references.

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Even you can Contact the editor of the journal.

Journal Review Time

Journals usually ask reviewers to provide their reviews within 3-4 weeks. However, few journals have a mechanism to enforce the deadline, which is why it can be hard to predict how long the peer review process will take.

The review time also depends upon the quality of a research paper.


Final Summary

  • The impact factor of European Neuropsychopharmacology is 5.415.
  • It is published by Elsevier.
  • The journal is indexed in UGC CARE, Scopus, SCIE.
  • The (SJR) SCImago Journal Rank is 1.603.
  • The European Neuropsychopharmacology is a reputed research journal.

Sources:

https://www.scopus.com/sourceid/15576







Similiar Journals


COMMUNITY MENTAL HEALTH JOURNAL
ISSN: 0010-3853
Publisher: SPRINGER

AUSTRALIAN JOURNAL OF PRIMARY HEALTH
ISSN: 1448-7527
Publisher: CSIRO PUBLISHING

INTERNET INTERVENTIONS-THE APPLICATION OF INFORMATION TECHNOLOGY IN MENTAL AND BEHAVIOURAL HEALTH
ISSN: 2214-7829
Publisher: ELSEVIER

PSYCHIATRIC SERVICES
ISSN: 1075-2730
Publisher: AMER PSYCHIATRIC PUBLISHING, INC

INTERNATIONAL JOURNAL OF MENTAL HEALTH PROMOTION
ISSN: 1462-3730
Publisher: TECH SCIENCE PRESS

JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS
ISSN: 1091-4358
Publisher: INT CTR MENTAL HEALTH POLICY & ECONOMICS-ICMPE

JMIR RESEARCH PROTOCOLS
ISSN: 1929-0748
Publisher: JMIR PUBLICATIONS, INC

JOURNAL OF PATIENT-REPORTED OUTCOMES
ISSN: 2509-8020
Publisher: SPRINGERNATURE

JOURNAL OF PATIENT SAFETY AND RISK MANAGEMENT
ISSN: 2516-0435
Publisher: SAGE PUBLICATIONS INC

LANCET REGIONAL HEALTH-EUROPE
ISSN: 2666-7762
Publisher: ELSEVIER

Top 20 Journals

Credit and Source: Scopus, Clarivate, UGC CARE.